Summary The study was originally set up to measure accurate cell kinetic parameters in two murine squamous cell carcinomas (scc) for comparison with radiobiological data on proliferation during radiotherapy. The tumours, AT84 and AT478, were both moderately well differentiated aneuploid scc. In the course of the study, several Tumour cell kinetic studies are not only essential in investigating the many factors regulating proliferation but have also been shown to be useful for predicting the response to therapy (Silvestrini et al., 1984; Tubiana et al., 1989; Begg et al., 1992; Begg, 1993) . Most cell kinetic studies have been carried out using either radio-labelled thymidine or a thymidine analog, which are incorporated into cells undergoing DNA synthesis. Such labelling of S-phase cells can be carried out in vivo or in vitro. In patients, administration of radiolabelled DNA precursors is precluded because of radiation hazards. Consequently, clinical studies have employed labelling of biopsy material in vitro (Silvestrini et al., 1984; Tubiana et al., 1989; The original goal of these studies was to measure accurately the cell kinetic parameters in two murine tumours for correlations with radiobiological characteristics of tumour proliferation during radiotherapy . The radiobiological data were available for tumours at two sizes, necessitating kinetic measurements at both these sizes. It was planned to use both FCM and IHC methods to ensure an accurate and correct description of the cell kinetics. The study was then also used to attempt to answer the questions posed above in these two well described animal tumour models. It thus provides comparisons of FCM and IHC methods, in vitro with in vivo labelling, single vs double labelling, the magnitude of intratumoural variations in kinetic parameters, in addition to the influence of tumour size.
Tumour cell kinetic studies are not only essential in investigating the many factors regulating proliferation but have also been shown to be useful for predicting the response to therapy (Silvestrini et al., 1984; Tubiana et al., 1989; Begg et al., 1992; Begg, 1993) . Most cell kinetic studies have been carried out using either radio-labelled thymidine or a thymidine analog, which are incorporated into cells undergoing DNA synthesis. Such labelling of S-phase cells can be carried out in vivo or in vitro. In patients, administration of radiolabelled DNA precursors is precluded because of radiation hazards. Consequently, clinical studies have employed labelling of biopsy material in vitro (Silvestrini et al., 1984; Tubiana et al., 1989; or administering non-radioactive thymidine analogs (Begg et al., 1992) . Several questions arise concerning such studies. The first is whether in vitro labelling is a reasonable substitute for in vivo labelling. The latter is not without potential risk, since the thymidine analogs used, iodo-and bromodeoxyuridine (BrdUrd and IdUrd) , are known mutagens although administered in low doses. In vitro labelling avoids such patient risk but includes potential artifacts involved in explanting tumour cells out of their natural environment. In addition, in vitro labelling requires immediate processing of tumour samples, while biopsies taken after in vivo labelling can be stored and analysed where and whenever is convenient. A related question is whether it is possible to measure, in vitro, not just the labelling index (LI; fraction of labelled cells) but also the DNA synthesis time, Ts. It has been shown possible to measure T, in vivo with one sample using thymidine analogs and flow cytometry (FCM), and various techniques for the analysis of such data have been developed White et al., 1991) , allowing the tumour potential doubling time Tpo, to be estimated. If Ts could also be measured in vitro in explanted biopsy material, Tpot could be estimated from purely in vitro data. A third question concerns the method of detection of the incorporated DNA precursor. Do immunohistochemical methods with thymidine analogs (equivalent to autoradiography with radiolabelled thymidine) have any advantage over FCM methods? FCM allows the quantitative measurement per cell of at least two parameters simultaneously, e.g. total DNA and BrdUrd incorporation. Immunohistochemistry (IHC) signals are inherently more difficult to quantify, but have the advantage of retaining positional and histological information.
The original goal of these studies was to measure accurately the cell kinetic parameters in two murine tumours for correlations with radiobiological characteristics of tumour proliferation during radiotherapy . The radiobiological data were available for tumours at two sizes, necessitating kinetic measurements at both these sizes. It was planned to use both FCM and IHC methods to ensure an accurate and correct description of the cell kinetics. The study was then also used to attempt to answer the questions posed above in these two well described animal tumour models. It (Denekamp & Kallman 1973; Chavaudra et al., 1979) (Begg et al., 1988) . Briefly, the fixed tumour pieces were cut into smaller pieces and incubated in a pepsin solution to produce a suspension of nuclei. This was followed by partial acid denaturation of DNA, incubation with a mouse monoclonal antibody specific for DNA-incorporated BrdUrd, incubation with an FITCconjugated anti-mouse antibody and addition of propidium iodide (PI) and RNase to stain total DNA. Flow cytometry was carried out using a FACStar flow cytometer (Becton Dickinson, Belgium) using excitation at 488 nm and collecting the green (FITC; BrdUrd) and red (PI; DNA) fluorescence signals using the following filters: 515-545 nm band pass (green), 650 nm long pass (red).
Immunohistochemistry (IHC) Two to four neighbouring, equatorial slices of 0.8 mm thickness were fixed in 2% paraformaldehyde in phosphate buffer, washed overnight in 6.8% sucrose in phosphate buffer and then embedded into glycolmethacrylate (Technovit 8100) as previously described (Schultz-Hector & Haghayegh, 1993) . Three ym tissue sections were mounted on poly-L-lysine coated slides. Labelled nuclei were visualised by 3H-TdR autoradiography, BrdUrd- immunohistochemistry, or by combination of both. For double staining, protease treatment with 0.1% trypsin in 0.1% CaCI2 at ph 7.8 for 10 min at 37°C, followed by 0.4% pepsin in 0.01 M HCI for 60 min at 37°C was performed before autoradiography. Slides were then coated with Kodak NTB 2 nuclear track emulsion diluted at 1:3 with distilled water. After exposure for 10 days at 4°C in the dark, autoradiographs were developed. In order to make the autoradiographic coating permeable for antibodies, slides were then dipped for 25 s into 0.2% trypsin in PBS at ph 7.2. Following DNA denaturation by 2 M HCI for 40 min, sections were incubated for 20 min with normal goat serum 1:20, for 2 h with mouse-anti-BrdUrd 1:40 (37°C), for 30 min with goat-anti-mouse 1:20 and finally for 30 min with alkaline-phosphatase-anti-alkaline-phosphatase (APAAP) complex. The alkaline phosphatase reaction was carried out using a naphthol AS-Bi-phosphate as substrate and new fuchsin as chromogen. All antibodies were obtained from DAKO (DAKO, Hamburg, Germany) and were diluted in 1 % bovine serum albumin solution in PBS. . The distinction between labelled and unlabelled cells was clear cut in these experimental tumours, with small differences in window placements having little or no influence on the estimated LI. At times longer than TG2, two separate labelled subpopulations were visible, representing undivided and divided cells. In this case, the number of divided cells (at the G, position) were divided by two when calculating the LI . Since it has been shown that unlabelled G2 cells have very little effect on the overall LI, they were not taken into account (Begg et al., 1989) . Both the tumours were aneuploid with DNA indices of approximately 1.7. Few labelled cells were seen above the diploid peak. The windows were placed around the aneuploid tumour population only. Ts was calculated by first estimating the parameter Relative Movement (RM) using a window placed around the undivided labelled cells and measuring their position relative to G, cells . T, was then calculated according to the equation:
where t is the time between BrdUrd injection and tumour excision. Again, only the aneuploid population was included.
Histology The transit of cells through S-phase was followed by sequential application of 3H-TdR and BrdUrd at intervals of 1-8 h. Tumours were excised and fixed 1 h after application of the second label. In histological sections the proportions of unlabelled, BrdUrd-labelled, In order to investigate the reason for this failure of cells to proceed through the cell cycle in vitro, tumour slices were re-incubated in medium at 37°C under hyperbaric oxygen conditions for time periods up to 6 h, before labelling with 50AM BrdUrd. The LI determined histologically decreased continuously after pre-incubation times of more than 3 h (Figure 2a) . In contrast, the LI determined by FCM was unchanged throughout the experiment (Figure 2b) . However, the fluorescence intensity of labelled nuclei, a measure of the DNA synthesis rate, decreased dramatically with increasing pre-incubation periods (Figure 2c) I a were areas where proliferating cells appeared to be randomly distributed (Figure 3a) . Often, tumour cells were arranged in cell nests, which were surround by blood vessels and which showed actively proliferating cells in their outer cell layers (Figure 3b ). On the other hand, chords of tumour cells surrounding a supporting blood vessel with maximum proliferative activity in their centre could also be found ( Figure  3c ). In the more slowly growing AT478/4, the two latter patterns were predominant, while in fast growing tumours AT478/25 and AT84, and especially in the tumour periphery of small tumours, a random staining pattern prevailed. In AT478/25 tumours, the actively proliferating tumour periphery was analysed separately from the more quiescent, but still viable central areas in order to quantitate regional differences in Tpot In the periphery, the labelling index was 35% and a Ts of 10 h was estimated, while in the centre the LI dropped to 10.8% and Ts increased to 22.5 h. Thus, within one tumour, different local values of values ranging from 1 to 7 days can be calculated (Figure 4) . In terms of three-dimensional tissue volumes however, the quiescent tumour centre (Figure 4b ) represents only a very minor proportion of the tumour volume. Since the LI is low in the tumour centre, this cell population is relatively under- represented in an overall analysis of tumour T, (Table I) 
3H-TdR vs BrdUrd
Comparison of LIs obtained after labelling with 3H-TdR or BrdUrd has yielded a good correlation in some studies (Meyer et al., 1989; Wilson et al., 1985) , while other authors reported a greater sensitivity of the BrdUrd technique . In the present study, no difference between 3H-TdR and BrdUrd LI values were seen, indicating the equivalence of the two techniques in our hands. Simultaneous application of 3H-TdR and BrdUrd in vivo, however, was reported to require an increase in either 3H-TdR dose or autoradiographic exposure time in order to obtain a constant 3H-TdR LI (Hume & Thompson, 1989) , while the BrdUrd LI was the same in single and double labelling experiments. In order to prevent a possible inhibition of 3H-TdR uptake by BrdUrd, 3H-TdR was always given prior to BrdUrd in the present study. Since there was no systematic or significant difference in 3H-TdR and BrdUrd LIs in double labelling experiments, an interaction between these two precursors appears to have been insignificant.
Can T, of explants be measured in vitro?
One goal of the study was to assess the feasibility of estimating Ts after in vitro labelling of tumour biopsies, thus circumventing the necessity of systemic application of DNA precursors in patients. Although LI values were not altered by pre-incubation of tumour slices for up to 3 h at 37°C and much longer time periods at lower temperatures, neither double labelling nor progression through the cycle measured by flow cytometry could be achieved. This could not be modified by hyperbaric oxygen, reduction of precursor concentrations to non-toxic levels or the addition of extra growth factors in the form of foetal calf serum. Similar difficulties had been encountered using radioactive labelling techniques, as summarised by Steel (1977) . Tumour cells with a DNA content between GI and G2 but negative for BrdUrd have been described in several studies (de Fazio et al., 1987; Wilson et al., 1985) . In addition, S-phase arrest can be induced in leukaemia cells by incubation with ARA-C, IFN or an IL-1 receptor antagonist (Preisler et al., 1992) . However, S-phase arrest is not a usual physiological mechanism of cell cycle control but probably occurred in these experiments because of the in vitro conditions. It is not clear how this can be circumvented, although other oxygenation conditions, incubation times and/or growth factors need to be tested. We conclude that a purely in vitro estimation of Ts by relative movement or double labelling is impossible using standard techniques.
Is measurement methods: single vs double labelling The double labelling technique used in the present study for histological assessment of Ts combines 3H-TdR autoradiography with BrdUrd IHC, as suggested by Hamada (1985) . It is based on quantifying the proportion of cells exiting or entering S-phase during the interval between labels and thus containing only one label rather than two (Wimber & Quastler, 1963) . Double labelling can also be performed using two different radioisotopes to label thymidine, which can then be deteced in different layers of autographic emulsion (Schultzê , 1976) . Alternatively, non-radioactive techniques have been developed using two different thymidine analogues which can be recognised by specific antibodies. However, cross-reactivity of these antibodies could be a problem in both IHC methods (Shibui et al., 1989; Hoshino et al., 1986) and FCM (Bakker et al., 1989; Raza, 1987 (Figure 3a) . T. estimates have also been derived from quantitative analysis of nuclear uptake of one single radioactive DNA precursor (Dormer, 1973) . However, this requires analysis of the whole nucleus, which is only possible in cell smears. In this study, the T, values measured by FCM, using a single analog and the Relative Movement method, were insignificantly different from those measured by the double label IHC/autoradiography technique ( Table I ). The present technique using a combination of IHC and autoradiography could also be applied to clinical material. In vivo labelling with BrdUrd could be followed by in vitro labelling with 3H-TdR, provided that tumour exision is delayed for several hours, until a time interval suitable for measurement of cell cycle progression has elapsed and in vitro incubation can be performed immediately after surgery. In addition to the advantages mentioned above, this would mean that administration to the patient of two labels could be avoided. However, neither this or other studies have yet shown that double labelling has advantages over the FCM single labelling method.
Tumour size dependence Comparison of small, i.e. 100 mg and large, i.e. 600 mg tumours showed a significant increase in T. with tumour size.
While small tumours had little of no necrosis, large tumours had developed fairly extensive areas of necrosis which were presumably surrounded by a zone of hypoxic but viable cells. Since a retarding effect of hypoxia on cycle progression has been observed both in vitro (Born et al., 1976) and in vivo , the tumour size related increase in T, may be due to increased tumour hypoxia. When tested functionally however, the time course of repopulation was found identical in small and large AT478 tumours .
The LI and Ts values obtained in the present study are longer than in most other reports on experimental tumours (reviewed by Denekamp, 1970 and by Steele, 1977; Carlton et al., 1991) . However, both tumour lines investigated in the present study were fairly well differentiated and slowly growing. Although the LI values reported here are higher than in most human tumours (Meyer & He, 1993) , they are lower than in the majority of experimental tumours described (Denekamp, 1970 and Steele, 1968) . A fast, late passage and a slow, early generation of one tumour line differed in LI, growth fraction and cell loss factor, but not in Ts.
Regional variations in LI and T7
In human head and neck squamous cell carcinomas, Bennett et al. (1992) observed is rather small and should be below an average sized clinical tumour biopsy. This is in good agreement with the finding of a moderate to low intratumoural variability when several biopsies from one human tumour were compared (Begg et al., 1988; Wilson et al., 1988; Bennett et al., 1992) . Begg et al. (1988) (Begg & Hofland, 1991; Raemakers et al., 1986) . Intratumoural variability can also better be studied with IHC techniques where only a gross estimate can be made with FCM. Finally, the present results suggest that T, cannot be accurately measured in fresh tumour explants by in vitro labelling, either by FCM or IHC methods. Therefore for patient studies requiring T, estimates, in vivo labelling remains the only choice at present.
